or Try an Advanced Search...

    Technical Analysis for PCSA - Processa Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 1.56 -6.02% -0.10
    PCSA closed down 6.02 percent on Thursday, April 18, 2024, on 26 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PCSA trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Calm After Storm Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Slingshot Bearish Bearish Swing Setup -6.02%
    Calm After Storm Range Contraction -6.02%
    Lower Bollinger Band Walk Weakness -6.02%
    Wide Bands Range Expansion -6.02%
    Oversold Stochastic Weakness -6.02%
    Hammer Candlestick Bullish 1.30%
    Older End-of-Day Signals for PCSA ...

       Recent Intraday Alerts

    Alert Time
    Slingshot Bearish Entry about 2 hours ago
    Fell Below Previous Day's Low about 2 hours ago
    Possible NR7 about 4 hours ago
    Possible Inside Day about 4 hours ago
    60 Minute Opening Range Breakdown about 5 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PCSA Chart by TradingView
    Basic chart:

    Profile

    Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its product pipeline is PCS499, which is use for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on October 2, 2017 and is headquartered in Hanover, MD.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Drug Products

    Is PCSA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 11 Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial
    Apr 7 Insider Buyers At Processa Pharmaceuticals Recover Some Losses, But Still Down US$40k
    Mar 28 Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
    Mar 25 Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting
    Feb 21 Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
    Feb 14 Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference
    Feb 9 How Is The Market Feeling About Processa Pharma?
    Feb 8 Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
    Feb 6 Processa Pharmaceuticals regains compliance with Nasdaq minimum bid price rule
    Feb 6 Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
    See more PCSA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 18.0
    52 Week Low 1.4
    Average Volume 239,392
    200-Day Moving Average 6.25
    50-Day Moving Average 2.26
    20-Day Moving Average 2.16
    10-Day Moving Average 2.02
    Average True Range 0.32
    RSI (14) 35.48
    ADX 20.73
    +DI 24.56
    -DI 31.39
    Chandelier Exit (Long, 3 ATRs) 2.35
    Chandelier Exit (Short, 3 ATRs) 2.35
    Upper Bollinger Bands 3.04
    Lower Bollinger Band 1.28
    Percent B (%b) 0.16
    BandWidth 81.31
    MACD Line -0.24
    MACD Signal Line -0.16
    MACD Histogram -0.0785
    Fundamentals Value
    Market Cap 2.66 Million
    Num Shares 1.71 Million
    EPS -22.80
    Price-to-Earnings (P/E) Ratio -0.07
    Price-to-Sales 0.00
    Price-to-Book 0.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.81
    Resistance 3 (R3) 1.82 1.75 1.77
    Resistance 2 (R2) 1.75 1.68 1.74 1.76
    Resistance 1 (R1) 1.65 1.64 1.62 1.64 1.74
    Pivot Point 1.58 1.58 1.56 1.57 1.58
    Support 1 (S1) 1.48 1.51 1.45 1.48 1.38
    Support 2 (S2) 1.41 1.47 1.41 1.36
    Support 3 (S3) 1.32 1.41 1.35
    Support 4 (S4) 1.31